Concepedia

Qingjie Mou

QM

Statistics

Publications

4

Citations

207

H-Index

4

Active since

2012

Affiliations

Weifang Medical University(Current)

Qingjie Mou is an author at Weifang Medical University specializing in medicine, oncology, and molecular oncology.

Publications per year

2012–2019

4

Publications

4

MiR-486-5p inhibits IL-22-induced epithelial-mesenchymal transition of breast cancer cell by repressing Dock1

Hongli Li, Qingjie Mou, Peirui Li et al. · Journal of Cancer · 2019 · 78 citations · Full text

, , +17

Identification of candidate diagnostic and prognostic biomarkers for human prostate cancer: RPL22L1 and RPS21

Zumu Liang, Qingjie Mou, Zhiwei Pan et al. · Medical Oncology · 2019 · 59 citations

, , +14

<i>MiR‐577</i> suppresses epithelial‐mesenchymal transition and metastasis of breast cancer by targeting Rab25

Chonggao Yin, Qingjie Mou, Xinting Pan et al. · Thoracic Cancer · 2018 · 58 citations · Full text

, , +17

Predictive value of ankle-brachial index and blood glucose on the outcomes of six-year all-cause mortality and cardiovascular mortality in a Chinese population of type 2 diabetes patients.

Yukun Wang, Qingjie Mou, Di Zhao et al. · PubMed · 2012 · 12 citations

, , +13

1–4 of 4